Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease

International Journal of Biological Sciences

Volumn 6, Issue 7, 2010, Pages 796-805

  Chun, Yong Soon ^a   Chaudhari, Pooja ^a   Jang, Yoon Young ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disease modeling; Drug screening; Liver disease; Stem cell

Indexed keywords

EID: 78650469789     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.796     Document Type: Review

References (75)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-76
2. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-72
3. Yu J, Vodyanik MA, Smuga Otte-K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917-20
4. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451:141-6
5. Park IH, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134:877-86
6. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321:1218-21
7. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009; 114: 5473-5480.
8. Raya A, Rodriguez-Piza I, Guenechea G et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460:53-9
9. Ku S, Soraguni E, Campau E et al. Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA·TTC triplet repeat instability. Cell Stem Cell 2010; 7:631-7
10. Lee G, Papapetrou EP, Kim H et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009; 461:402-6
11. Ebert AD, Yu J, Rose FF Jr et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457:277-80
12. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136:964-77
13. Ye L, Chang JC, Lin C et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic disease. Proc Natl Acad Sci USA 2009; 106:9826-30
14. Carvajal-Vergara X, Sevilla A, D'Souza SL et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010; 465:808-12
15. Rashid ST, Corbineau S, Hanna N et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010; 120:3127-36
16. Ghodsizadeh A, Taei A, Totonchi M et al. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev and Rep 2010; 6:622-32
17. Marchetto MC, Carromeu C, Acab A et al. A model for neural development and treatment of rett syndrome using human induced pluripotent stem cells. Cell 2010; 143:527-39
18. Zhang N, An MC, Montoro D et al. Characterization of human Huntington's disease cell model from induced pluripotent stem cells. PLos Curr 2010; 2:RRN1193
19. Song Z, Cai J, Liu Y et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009; 19:1233-42
20. Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008; 26:1117-27
21. Sullivan GJ, Hay DC, Park IH et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010; 51:329-35
22. Liu H, Ye Z, Kim Y et al. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010; 51:1810-19
23. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115:209-18
24. Haridass D, Narain N, Ott M. Hepatocyte transplantation: waiting for stem cells. Curr Opin Organ Transplant 2008; 13:627-32
25. Herrera MB, Bruno S, Buttiglieri S et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006; 24:2840-50
26. Lazaro CA, Rhim JA, Yamada Y et al. Generati on of hepatocytes from oval cell precursors in culture. Cancer Res 1998; 58:5514-22
27. Sahin MB, Schwartz RE, Buckley SM et al. Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver. Liver Transpl 2008; 14:333-45
28. Czyz J, Wiese C, Rolletschek A et al. Potential of embryonic and adult stem cells in vitro. Biol Chem 2003; 384:1391-409
29. Okita K, Ichisaka T, Yamanaka S. Generation of germline- competent induced pluripotent stem cells. Nature 2007; 448:318-24
30. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26:101-6
31. Kaji K, Norrby K, Paca A et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458:771-5
32. Woltjen K, Michael IP, Mohseni P et al. piggyback transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458:766-70
33. Stadtfeld M, Nagaya M, Utikal J et al. Induced pluripotent stem cells generated without viral integration. Science 2008; 322:945-9
34. Fusaki N, Ban H, Nishiyama A et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85:348-62
35. Okita K, Nakagawa M, Hyenjong H et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322:949-53
36. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324:797-801
37. Huangfu D, Maehr R, Guo W et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26:795-7
38. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4:381-4
39. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cell with synthetic modified mRNA. Cell Stem Cell 2010; 7:618-30
40. Miura K, Okada Y, Aoi T et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 2009; 27:743-45
41. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467:280-1
42. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnol 2010; 28:848-55
43. Marchetto MCN, Yeo GW, Kainohana O et al. Transcriptional signature and memory retention of human induced pluripotent stem cells. PLoS One 2009; 4:e7076
44. Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocelluar tumors. Oncogenes 2006; 25:3778-86
45. Bluteau O, Jeannot E, Bioulac Sage P et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32:312-5
46. Wong CM, Fan ST, Ng IO. Beta-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 2001; 92:136-45
47. Tanaka S, Toh Y, Adachi E et al. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 1993; 53:2884-7
48. Choi SM, Liu H, Kim Y et al. Multistage hepatic differentiation from human induced pluripotent stem cells. Methods and Protocols 2010, in press
49. Carette JE, Pruszak J, Varadarjan M et al. Generation of iPSCs from cultured human malignant cells. Blood 2010; 115:4039-42
50. Miyoshi N, Ishii H, Nagai K et al. Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA 2010; 107:40-5
51. Si-Tayeb K, Noto FK, Nagaoka M et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51:297-305
52. Maehr R, Chen S, Snitow M et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 2009; 106:15768-73
53. Rubin LL. Stem cells and drug discovery: the beginning of a new era? Cell 2008; 132:549-52
54. Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318:1920-3
55. Overturf K, al-Dhalimy M, Ou CN et al. Serial transplantation reveals the stem-cell- like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997; 151:1273-80
56. Rhim JA, Sandgren EP, Degen JL et al. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263:1149-52
57. Sandgren EP, Palmiter RD, Heckel JL et al. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991; 66:245-56
58. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nature Cell Biol. 2004; 6: 532-9.
59. Seifinejad A, Tabebordbar M, Baharvand H et al. Progress and promise towards safe induced pluripotent stem cells for therapy. Stem Cell Rev and Rep 2010; 6:297-306
60. Loh YH, Agarwal S, Park IH et al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113:5476-9
61. Staerk J, Dawlaty MM, Gao Q et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cell. Cell Stem Cell 2010; 7:20-4
62. Kunisato A, Wakatsuki M, Shinba H et al. Direct generation of induced pluripotent stem cells from human nonmobilized blood. Stem Cells Dev 2010; [Epub ahead of print]
63. Seki T, Yuasa S, Oda M et al. Generation of induced pluripotent stem cells from human terminally differentiated circulation T cells. Cell Stem Cell 2010; 7:11-4
64. Brown ME, Rondon E, Rajesh D et al. Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLos One 2010; 5:e11373
65. Loh YH, Hartung O, Li H et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010; 7:15-9
66. Haase A, Olmer R, Schwanke K et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009; 5:434-41
67. Eminli S, Foudi A, Stadtfeld M et al. Differentiation stage determines potential of hematopoietic cells fro reprogramming into induced pluripotent stem cells. Nat Genet 2009; 41:968-76
68. Giorgetti A, Montserrat N, Aasen T et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009; 5:353-57
69. Sugii S, Kida Y, Kawamura T et al. Human and mouse adipose- derived cells support feeder-independent induction of pluripotent stem cells. Proc Natl Acad Sci USA 2010; 107:3558-63
70. Aoki T, Ohnishi H, Oda Y et al. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Eng Part A 2010; 16:2197-206
71. Oda Y, Yoshimura Y, Ohnishi H et al. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem 2010; 285:29270-8
72. Aasen T, Raya A, Barrero MJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26:1276-84
73. Kim JB, Greber B, Arauzo-Bravo MJ et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009; 461:649-53
74. Utikal J, Maherali N, Kulalert W et al. Sox2 is dispensible for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 2009; 122:3502-10
75. Yang J, Cai J, Zhang Y et al. Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader Willi syndrom. J Biol Chem 2010; [Epub ahead of print]